11-2 Expression in Different Levels of Celiac Disease Patients

Authors

  • Mahmood Shaker Jabbar Department of Pathological Analyses, Faculty of Science, University of Kufa, Najaf, Iraq. Author
  • Muslim Idan Mohsin Department of Pathological Analyses, Faculty of Science, University of Kufa, Najaf, Iraq Author

Keywords:

IL-2, CD, qPCR, Gluten and Relapsed Cases.

Abstract

 Celiac disease (CD) is an autoimmune gastrointestinal ailment brought on by the ingestion of peptides found in wheat, rye, barley, and potentially oats in people who are genetically predisposed to developing the disease. Gluten, the cohesive protein mass generated by washing wheat dough to remove starch and other water-soluble components, has been labelled as dangerous proteins. Celiac disease is poorly known, including its method of presentation and immune response mechanism. To better understand the immunological response generated by celiac disease, this study analysed the demographic and clinical characteristics of 200 patients with whole blood and serum from the disease. ELIZA and qPCR were also used to measure the amount of IL-2 in the gene and serum at different stages of disease. The finding shows that IL-2 is an important part of the immune response at different stages of disease. The data showed that the titters of people with a new disease were much higher than those of healthy people. However, the titters of healthy people didn’t change when they were treated or kept away from gluten. It seems that IL-2 may have a direct role with celiac disease not only at the first stage of diseases but also at relapsed cases. 

Downloads

Download data is not yet available.

References

Rubin JE, Crowe SE. Celiac disease. Annals of internal medicine.

;172(l):ITCl-ITC16.

Lebwohl B, Rubio-Tapia A. Epidemiology, presentation, and

diagnosis of celiac disease. Gastroenterology. 2021;160(1):63-75.

Ramirez-Sanchez AD, Tan IL, Gonera-de Jong B, Visschedijk MC,

Jonkers I, Withoff S. Molecular biomarkers for celiac disease: Past, present and future. International Journal of Molecular Sciences.

;21(22):8528.

Hearn NL, Chiu CL, Lind JM. Comparison of DNA methylation

profiles from saliva in Coeliac disease and non-coeliac disease

individuals. BMC Medical Genomics. 2020;13:1-11.

Shahriari M, Honar N, Yousefi A, Javaherizadeh H. Association of

potential celiac disease and refractory iron deficiency anemia in

children and adolescents. Arquivos de gastroenterologia.

;55:78-81.

Mohammadibakhsh R, Sohrabi R, Salemi M, Mirghaed MT,

Behzadifar M. Celiac disease in Iran: a systematic review and meta¬

analysis. Electronic physician. 2017;9(3):3883.

Molder A, Balaban DV, Jinga M, Molder C-C. Current evidence on

computer-aided diagnosis of celiac disease: Systematic review.

Frontiers in Pharmacology. 2020;11:341.

Iversen R, Sollid LM. The immunobiology and pathogenesis of

celiac disease. Annual Review of Pathology: Mechanisms of Disease.

;18:47-70.

Svigelj R, Zuliani I, Grazioli C, Dossi N, Toniolo R. An effective

label-free electrochemical aptasensor based on gold nanoparticles

for gluten detection. Nanomaterials. 2022;12(6):987.

Masaebi F, Looha MA, Rostami-Nejad M, Pourhoseingholi MA,

Mohseni N, Samasca G, et al. The predictive value of serum

cytokines for distinguishing celiac disease from non-celiac gluten

sensitivity and healthy subjects. Iranian Biomedical Journal.

;24(6):340.

Alkalay MJ. Update on celiac disease. Current opinion in pediatrics.

;32(5):654-60.

Bokhari HA, Shaik NA, Banaganapalli B, Nasser KK, Ageel HI, Al

Shamrani AS, et al. Whole exome sequencing of a Saudi family and

systems biology analysis identifies CPED1 as a putative causative

gene to Celiac Disease. Saudi Journal of Biological Sciences.

;27(6):1494-502.

Comino I, Segura V, Ortigosa L, Espin B, Castillejo G, Garrote JA,

et al. Prospective longitudinal study: use of faecal gluten

immunogenic peptides to monitor children diagnosed with coeliac

disease during transition to a gluten free diet. Alimentary

Pharmacology & Therapeutics. 2019;49(12):1484-92.

Lebwohl B, Sanders DS, Green PH. Coeliac disease. The Lancet.

;391(10115):70-81.

Van Kalleveen MW, de Meij T, Plotz FB. Clinical spectrum of

paediatric coeliac disease: a 10-year single-centre experience.

European Journal of Pediatrics. 2018;177:593-602.

Goel G, Daveson A, Hooi C, Tye-Din J, Wang S, Szymczak E, et al.

Serum cytokines elevated during gluten-mediated cytokine release

in coeliac disease. Clinical & Experimental Immunology.

;199(l):68-78.

Tye-Din JA, Skodje GI, Sarna VK, Dzuris JL, Russell AK, Goel G, et

al. Cytokine release after gluten ingestion differentiates coeliac

disease from self-reported gluten sensitivity. United European

gastroenterology journal. 2020;8(1):108-18.

McAllister CS, Kagnoff MF, editors. The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet. Seminars in immunopathology; 2012: Springer.

Downloads

Published

2023-04-30

Issue

Section

Articles

How to Cite

Shaker Jabbar, M., & Idan Mohsin, M. (2023). 11-2 Expression in Different Levels of Celiac Disease Patients. History of Medicine, 9(2). https://historymedjournal.com/HOM/index.php/medicine/article/view/486